Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 8
Submit an article Journal homepage
87
Views
17
CrossRef citations to date
0
Altmetric
NEW DRUGS

Anti-Angiogenic Treatment of Gastrointestinal Malignancies

J. Stuart Salmon Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, Tennessee, USA
, M.D.,
A. Craig Lockhart Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, Tennessee, USA
, M.D. &
Jordan Berlin Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, Tennessee, USA
, M.D.
Pages 712-726 | Published online: 11 Jun 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Erika Martinelli, Teresa Troiani, Floriana Morgillo, Michele Orditura, Fernando De Vita, Giulio Belli & Fortunato Ciardiello. (2013) Emerging VEGF-receptor inhibitors for colorectal cancer. Expert Opinion on Emerging Drugs 18:1, pages 25-37.
Read now
Teresa Troiani, Erika Martinelli, Michele Orditura, Ferdinando De Vita, Fortunato Ciardiello & Floriana Morgillo. (2012) Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer. Expert Opinion on Investigational Drugs 21:7, pages 949-959.
Read now
Rajni Sinha, Nutan DeJoubner & Christopher Flowers. (2011) Novel agents for diffuse large B-cell lymphoma. Expert Opinion on Investigational Drugs 20:5, pages 669-680.
Read now
Benjamin F Johnson, Timothy M Clay, Amy C Hobeika, H Kim Lyerly & Michael A Morse. (2007) Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy. Expert Opinion on Biological Therapy 7:4, pages 449-460.
Read now
C. Portlock. (2006) Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?. Leukemia & Lymphoma 47:6, pages 961-962.
Read now

Articles from other publishers (12)

Duanrui Liu, Xiaoli Ma, Dongjie Xiao, Yanfei Jia & Yunshan Wang. (2017) Efficacy and safety of targeting VEGFR drugs in treatment for advanced or metastatic gastric cancer: a systemic review and meta-analysis. Oncotarget 9:8, pages 8120-8132.
Crossref
David BarrasSevtap Savas. (2016) Biomarkers for Colon Cancer. Biomarkers in Cancer 7s1, pages BIC.S39882.
Crossref
Jian-Hua Yin, Xiao-Yan Zhu, Wei-Dong Shi & Lu-Ming Liu. (2014) Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft. BMC Complementary and Alternative Medicine 14:1.
Crossref
Angela L. Linderholm & Steven M. Chamow. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins 311 350 .
Marian Gil DelgadoFrançois Michel DelgadoDavid Khayat. (2014) Role of aflibercept in the treatment of advanced colorectal cancer. Colorectal Cancer 3:1, pages 27-40.
Crossref
Tzu-Fei WangAlbert Craig Lockhart. (2012) Aflibercept in the Treatment of Metastatic Colorectal Cancer. Clinical Medicine Insights: Oncology 6, pages CMO.S7432.
Crossref
Shuhei SakakibaraGiovanna Tosato. (2009) Regulation of angiogenesis in malignancies associated with Epstein–Barr virus and Kaposi’s sarcoma-associated herpes virus. Future Microbiology 4:7, pages 903-917.
Crossref
Cornelis Verhoef, Johannes H.W. de Wilt, Timo L.M. ten Hagen & Alexander M.M. Eggermont. (2008) Isolated Hepatic Perfusion for the Treatment of Liver Tumors: Sunset or Sunrise?. Surgical Oncology Clinics of North America 17:4, pages 877-894.
Crossref
Cornelis Verhoef, Johannes H. W. de Wilt, Flavia Brunstein, Andreas W. K. S. Marinelli, Boudewijn van Etten, Maarten Vermaas, Gunther Guetens, Gert de Boeck, Ernst A. de Bruijn & Alexander M. M. Eggermont. (2008) Isolated Hypoxic Hepatic Perfusion with Retrograde Outflow in Patients with Irresectable Liver Metastases; A New Simplified Technique in Isolated Hepatic Perfusion. Annals of Surgical Oncology 15:5, pages 1367-1374.
Crossref
Ioannis G. Baraboutis, Vassilios Papastamopoulos, Georgios Charitsis, Lazaros J. Lekakis, Michael M. Vaslamatzis & Athanasios T. Skoutelis. (2008) First-time use of bevacizumab for aggressive, metastatic hepatocellular carcinoma in an HIV/hepatitis B virus coinfected patient: a case report. European Journal of Gastroenterology & Hepatology 20:5, pages 472-473.
Crossref
Giuseppe PasqualettiRomano DanesiMario Del TaccaGuido Bocci. (2007) Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics 8:1, pages 49-66.
Crossref
J E M Crozier, R F McKee, C S McArdle, W J Angerson, J H Anderson, P G Horgan & D C McMillan. (2006) The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. British Journal of Cancer 94:12, pages 1833-1836.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.